Skip to main content
!
Updates on the University COVID-19 response and operations available here.
!
Updates on the University COVID-19 response and operations available here.
!
Updates on the University COVID-19 response and operations available here.
Displaying 142 of 2778 articles.

Noninfectious versions of SARS-CoV-2 provide powerful research tools

The new experimental system will facilitate efforts to study different coronavirus variants and develop new drugs for
  • Read more

  • Small molecule may prevent metastasis in colorectal cancer

    The compound works by hindering a key pathway that cancer cells rely upon to hoard energy, and is already undergoing clinical trials.


    Study detects origins of Huntington's disease in two-week-old human embryos

    The findings shed new light on the root causes of this disease, which leads to the degeneration of neurons in midlife.

    >

    Novel method for trapping HIV inside its host may give rise to new antivirals

    Human cells can be coaxed into preventing certain enveloped viruses (including HIV, Ebola, and parainfluenza) from escaping their membranes in the lab, a finding that could lead to novel treatments for many viral diseases.

    Could future coronavirus variants fully dodge our immune system?

    Studying dozens of naturally occurring and laboratory-selected mutations in SARS-CoV-2, researchers found that the virus will need to pull off a genetic feat to become fully resistant to antibodies.

    Toward the first drug to treat a rare, lethal liver cancer

    After scouring more than 5,000 compounds, scientists have identified several new classes of therapeutics that may help treat fibrolamellar carcinoma.

    New findings to boost IVF success rates

    New research casts doubt on a genetic test used to screen would-be embryos for IVF implantation. The findings suggests that these embryos can develop into healthy babies regardless of whether or not they’ve been flagged as defective by the test.

    Paul Cohen, expert on fat, is promoted to associate professor

    Cohen, a physician-scientist exploring obesity and metabolic disease, has conducted groundbreaking research on the complex inner workings of fat tissue.

    Immunologist Daniel Mucida promoted to professor

    A pioneer in the field of mucosal immunology, Mucida is unlocking the secrets of the digestive system and answering fundamental questions about the origins of human disease.

    Synthetic “micro lungs” could take COVID-19 research to the next level

    Scientists have developed stem-cell technology to mass-produce tissue cultures resembling our breathing organs. These tissues offer a powerful model in which to study how SARS-CoV-2 wreaks havoc in the lungs and to screen for new drugs.